Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…
FDA Requests Anticonvulsant Suicide Data Analysis – Boston Globe Wed, 20 Apr 2005 Thanks to the persistent advocacy efforts of attorney, Andrew Finkelstein, the FDA has finally sent letters to 14 manufacturers of anticonvulsant drugs, such as Pfizer’s Neurontin, to examine the suicide data from these drugs. Finkelstein began his…
Date: Wed, 15 May 2002 12:57:32 -0400 Subject: Harvard President Laments China Study_Globe ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI Harvard’s genetic experiments in rural China have elicited much criticism. In December 2000, The Washington Post published a highly critical investigative…
Obesity Researcher AdmitsFabricating Data- $3 Mill Fraud in Gov Grants – Boston Globe Fri, 18 Mar 2005 The Boston Globe reports about the worst case of scientific fraud to come to light. Dr. Eric Poehlman, a star among obesity researchers, faces jail time. He overstated the effects of menopause on…
Success in academic psychiatry is not measured in the improvement of patients' mental health, but rather in quantifiable commercial tender.How many grants one brings to the university, how many publications one churns out each year, and how many corporate and professional advisory boards one serves on–and how much money one…
A Boston Globe report (below) focuses on three recent reports in the Journal of the American Medical Association (JAMA) by Harvard researchers who violated the journal’s disclosure policy by failing to disclose their financial ties to companies that had the most to gain from their purported findings.
The Times’ humorous profile of JAMA’s editor attempts to trivialize the threat to public health when journals fail to maintain the integrity of science-based medicine.
It is difficult to believe this latest announcement laying claim to a new "under treated" psychiatric disorder–Intermittent Explosive Disorder (IED) is not a parody !!
A ray of hope that might help cleanse medicine of its corrupt interaction with drug company marketers.
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [ ] to suffer while doctors search for something that works.”
"Lobbyists influence how the government spends your money, but financially conflicted physicians can threaten your well-being."
